KNBW.Y — Kirin Holdings' OTC American depositary receipt — heads into its May 14 earnings date with short interest on the rise and cost to borrow moving in the opposite direction, creating an unusual split in the lending market.
The most striking development this week is the near-tripling of short interest in the space of a month. Estimated short shares climbed 187% over the past week to roughly 60,400 shares, and are up 86% from a month ago. The official FINRA fortnightly figure, settled through April 15, confirms the trend — 53,799 shares short with days to cover just over one day, consistent with the thin float typical of an OTC-listed ADR. Given the absence of a calculable free-float figure for this listing, the absolute share count is the more meaningful signal here, and the direction is unambiguous: bears have been adding aggressively.
The lending market tells a less straightforward story. Cost to borrow has collapsed from its March highs near 6.3% to 1.25% today — a 71% decline over the month. That easing reflects a far larger pool of shares available to borrow relative to demand. Borrow availability, while running at moderate levels today, reached a 52-week high of 99.87% utilization as recently as earlier this year. The current utilization reading of 36.6% suggests the market is nowhere near a squeeze — there is still meaningful room for new shorts to enter without driving up borrowing costs sharply. Combined with the falling cost to borrow, the picture is one of increasing bearish activity in a market that, for now, is not punishing those positions with expensive financing.
Price action has been muted. The ADR closed at $15.49 on April 29, down 1% on the day and nearly 2% on the week, with no movement registered over the past month. The short score has moved modestly higher to 42.2 from 34.9 a fortnight ago — still in mid-range territory and not flashing an extreme signal. That alignment — rising SI, easing CTB, subdued price move — suggests the new short interest is being built quietly rather than in response to a sharp catalyst.
The institutional base is anchored by large passive holders. BlackRock holds 7.8% of shares, followed by Nomura Asset Management at 4.9% and Vanguard at 4.2%. Between them, the passive Japanese and international institutional block is substantial, which may in part explain why the OTC-listed ADR sees relatively contained short-side pressure despite the recent pickup. On the operational side, Kirin's subsidiary Kyowa Kirin this week initiated a Phase II trial of ziftomenib for AML alongside Kura, adding a clinical-stage catalyst to watch in the biopharmaceuticals arm. Kirin Beverage separately announced a ¥10 billion capital investment in small PET bottle production at its Shiga plant, signalling continued commitment to its beverages business.
With earnings due May 14, what to watch is whether the short-building accelerates into the announcement — particularly whether borrowing costs start rising again as availability tightens — or whether the positions cover on any positive surprise from the biopharma pipeline or the core beverages segment.
See the live data behind this article on ORTEX.
Open KNBW.Y on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
